In a recent @thrombosis-update.bsky.social article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance. Read more here: sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

New article in @thrombosis-update.bsky.social Researchers suggest that patients with multiple or high-titer antiphospholipid antibodies face a seven to 21-fold increased risk of severe mental illness. #APS #TruUpdate @lucynortcd.bsky.social

New article in @thrombosis-update.bsky.social "A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks" Read more: here:https://www.sciencedirect.com/science/article/pii/S2666572725000264

A new study in @thrombosis-update.bsky.social reveals that #VTE -related deaths are over three times higher in LA County jails than in the general population. #HealthEquity #PublicHealth #Incarceration Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

New article in @thrombosis-update.bsky.social 👇 Findings from a phase 2 trial show that Auxora™ may help patients with severe #COVID19 by reducing D-dimer levels. @lucynortcd.bsky.social #TruJournal Read more here: www.sciencedirect.com/science/arti...

A new study in #ThrombosisUpdate reveals what patients value in thrombosis care! Clear info & respectful relationships are key to satisfaction, but virtual options and affordable medication are areas for improvement. @lucynortcd.bsky.social Read more here: www.sciencedirect.com/science/arti...

A new study in @thrombosis-update.bsky.social shows that freezing plasma samples doesn't significantly affect #thrombin generation measurements over long-term storage (up to 2 years at -80°C). @lucynortcd.bsky.social #TruJournal Read more here: www.sciencedirect.com/science/arti...

A new multicenter study in @thrombosis-update.bsky.social from Colombia characterizes anticoagulation reversal practices, revealing bleeding as the primary indication and warfarin as the most common anticoagulant. @lucynortcd.bsky.social #TruJournal Full text: www.sciencedirect.com/science/arti...

In this @thrombosis-update.bsky.social article, the authors found that underdosing #DOACs for nonvalvular atrial fibrillation is linked to higher risks of stroke and major bleeding compared to on-label dosing. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

New study in @thrombosis-update.bsky.social reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

A new case study in @thrombosis-update.bsky.social on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

What goes into deciding about #Antithrombotic therapy for #cancer patients at end of life? 🤔 The #SERENITY project is finding out! Read more here in @thrombosis-update.bsky.social www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

New meta-analysis in @thrombosis-update.bsky.social on aspirin for infective endocarditis reveals mixed results for preventing embolic events. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

Why is #VTE mortality falling in Finland🇫🇮 despite soaring #PE incidence? 📉 A nationwide registry study in @thrombosis-update.bsky.social reveals key trends, including stable DVT rates & a surge in diagnostic imaging. Important and🗝️ findings for #VTE epidemiology. @lucynortcd.bsky.social

Safe #PE treatment for #cancer patients? Ultrasound-guided thrombolysis #CDT shows promise! New study in @thrombosis-update.bsky.social found similar low bleeding rates in cancer & non-cancer patients. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

Don’t miss out! 🚨 Early registration for #ISTH2025 closes April 22! Register now to score the lowest rates and guarantee your spot at the premier event for cutting-edge science, expert insights & unforgettable connections. Lock in➡️https://www.isth2025.org/

From molecular mechanisms to clinical breakthroughs, @thrombosis-update.bsky.social covers it all! Submit your original research, reviews, or case reports today. www.sciencedirect.com/journal/thro... @lucynortcd.bsky.social #TruJournal

Is there a better way to predict pulmonary thromboembolism #PTE mortality? 🤔 New research in @thrombosis-update.bsky.social says RV/LV ratio on #CTPA might be the key. Find out more: how:https://www.sciencedirect.com/science/article/pii/S2666572725000069?via%3Dihub #TruJournal

Critically ill #COVID19 patients on heparin? New study in @thrombosis-update.bsky.social reveals aPTT & anti-Xa monitoring often clash, impacting bleeding risk. Switching to anti-Xa guidance? Could mean fewer #Bleeding events. Read more here: www.sciencedirect.com/science/arti...

One size doesn't fit all: DOACs for VTE in inherited thrombophilia need tailored approaches. New findings in @thrombosis-update.bsky.social emphasize patient-centered care. Read the full text here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

This new study in @thrombosis-update.bsky.social investigates how multimorbidity and its severity, along with specific disease clusters, relate to the risk of #VTE. @lucynortcd.bsky.social #TruJournal Read more here at: www.sciencedirect.com/science/arti...

A study in @thrombosis-update.bsky.social the authors found that rosuvastatin did not prevent thrombus formation nor speed up resolution. #VTE #TruJournal Read the full article to learn morehttps://www.sciencedirect.com/science/article/pii/S2666572725000033?via%3Dihub @lucynortcd.bsky.social

This recent study in @thrombosis-update.bsky.social compared the safety and effectiveness of using a reduced apixaban lead-in vs. full lead-in dosing in #VTE. Read more here at: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #ThrJournal

The recent @thrombosis-update.bsky.social paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research. #ThrJournal @lucynortcd.bsky.social www.sciencedirect.com/science/arti...

Here is the editorial commentary by @lucynortcd.bsky.social and Dr. Papadakis on the article by Mateo et al. in @thrombosis-update.bsky.social in which ther authors presented the data from the TESEO registry. Read more here: www.sciencedirect.com/science/arti...

Tissue factor (TF aka F3) is the main initiator of blood coagulation. In this new @thrombosis-update.bsky.social study, the authors determined the molecular epidemiology and the importance of #F3 variants for incident #VTE Read more: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social